DURECT Management
Management criteria checks 3/4
DURECT's CEO is Jim Brown, appointed in Feb 1998, has a tenure of 26.75 years. total yearly compensation is $1.45M, comprised of 40.6% salary and 59.4% bonuses, including company stock and options. directly owns 0.59% of the company’s shares, worth $178.93K. The average tenure of the management team and the board of directors is 8.8 years and 5.6 years respectively.
Key information
Jim Brown
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 40.6% |
| CEO tenure | 26.8yrs |
| CEO ownership | 0.6% |
| Management average tenure | 8.8yrs |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
Brokers Are Upgrading Their Views On DURECT Corporation (NASDAQ:DRRX) With These New Forecasts
Aug 08
Durect names ex-RBC Capital Markets executive as CFO
Jul 05Is DURECT (NASDAQ:DRRX) A Risky Investment?
May 12DURECT Corporation (NASDAQ:DRRX) Analysts Are More Bearish Than They Used To Be
Mar 14DURECT Corporation (NASDAQ:DRRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 10Does DURECT (NASDAQ:DRRX) Have A Healthy Balance Sheet?
Jan 08Is DURECT (NASDAQ:DRRX) Using Debt Sensibly?
Aug 05Durect (DRRX) Investor Presentation - Slideshow
May 06Durect EPS misses by $0.01, misses on revenue
May 04DURECT prices ~$43M stock offering
Feb 04DURECT surges after FDA approval for Posimir
Feb 02Durect's DUR-928 fast track'd for alcoholic hepatitis in the U.S.
Dec 16DURECT (DRRX) Investor Presentation - Slideshow
Oct 31CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$17m |
| Jun 30 2024 | n/a | n/a | -US$16m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$1m | US$586k | -US$28m |
| Sep 30 2023 | n/a | n/a | -US$37m |
| Jun 30 2023 | n/a | n/a | -US$36m |
| Mar 31 2023 | n/a | n/a | -US$36m |
| Dec 31 2022 | US$2m | US$575k | -US$35m |
| Sep 30 2022 | n/a | n/a | -US$32m |
| Jun 30 2022 | n/a | n/a | -US$39m |
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$1m | US$555k | -US$36m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$37m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$1m | US$539k | -US$14m |
| Sep 30 2020 | n/a | n/a | -US$11m |
| Jun 30 2020 | n/a | n/a | -US$3m |
| Mar 31 2020 | n/a | n/a | -US$24m |
| Dec 31 2019 | US$1m | US$531k | -US$21m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$24m |
| Mar 31 2019 | n/a | n/a | -US$24m |
| Dec 31 2018 | US$1m | US$531k | -US$25m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$962k |
| Mar 31 2018 | n/a | n/a | -US$4m |
| Dec 31 2017 | US$1m | US$531k | -US$4m |
Compensation vs Market: Jim's total compensation ($USD1.45M) is above average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
CEO
Jim Brown (67 yo)
26.8yrs
Tenure
US$1,445,784
Compensation
Dr. James E. Brown, also known as Jim, D.V.M., serves as Life Science Advisor since 2021 at K2X Technology & Life Science, Inc. He Co-founded DURECT Corporation in February 1998 and has been its President...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 26.8yrs | US$1.45m | 0.59% $ 178.9k | |
| CFO & Secretary | 2.3yrs | US$671.31k | 0% $ 0 | |
| Chief Medical Officer | 4yrs | US$654.48k | 0.0029% $ 873.2 | |
| Senior Vice President of Operations & Corporate Quality Assurance | 10.7yrs | US$713.55k | no data | |
| Executive VP of Research & Development and Principal Scientist | no data | no data | no data | |
| Senior VP of Finance | 23.6yrs | US$452.77k | no data | |
| Executive Officer | 6.8yrs | US$430.63k | no data |
8.8yrs
Average Tenure
67yo
Average Age
Experienced Management: DRRX's management team is seasoned and experienced (8.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 26.4yrs | US$1.45m | 0.59% $ 178.9k | |
| Independent Chairman of the Board | 3.8yrs | US$109.74k | 0.064% $ 19.4k | |
| Independent Director | 3.8yrs | US$81.62k | 0.019% $ 5.8k | |
| Independent Director | 17.9yrs | US$83.12k | 0.010% $ 3.0k | |
| Independent Director | 2.9yrs | US$84.73k | 0.023% $ 6.8k | |
| Independent Director | 5.6yrs | US$83.12k | 0.11% $ 34.5k | |
| Independent Director | 5.6yrs | US$70.62k | 0.032% $ 9.7k |
5.6yrs
Average Tenure
67yo
Average Age
Experienced Board: DRRX's board of directors are considered experienced (5.6 years average tenure).